Craig A.Waldman

Craig Waldman, who co-chairs Jones Day's global Antitrust & Competition Law Practice, and also chairs the Firm's Tech Practice, has more than 30 years of experience representing companies in high-stakes antitrust government investigations, private litigations, and by counseling them on how to manage antitrust risk in daily business activities. Craig's work has included all areas of antitrust including mergers, agreements among competitors, vertical distribution issues, price discrimination, criminal antitrust matters, monopolization, and intellectual property licensing and trade regulation.

He has worked across many industries, including IT hardware and software, networking, solar, health care, food, consumer products, credit cards, ESG (environmental, social, and governance), financial institutions, energy, medical devices, defense, sports, financial markets, life sciences, oil and gas, retail stores, satellites, telecommunications, tobacco, and transportation. The companies Craig represents include P&G, Boeing, Medtronic, Wabtec, Autodesk, BAT, and Synopsys.

From 1993 to 1996, Craig served as an attorney in the FTC's Mergers I division during which time he was involved in high-profile investigations, including Rite Aid's attempted acquisition of Revco, Lockheed's purchase of Martin Marietta, First Financial's merger with First Data, and Glaxo's acquisition of Wellcome.

Craig is a frequent speaker on all antitrust issues. He has served as an adjunct professor at both Berkeley and Hastings law schools, has lectured at Stanford Business School, and has served in numerous roles within ABA Antitrust Leadership.

For over 10 years, he has served on the board of directors of Global Strategies, an international charity whose mission is to reduce early mortality and treat survivors of sexual violence in impoverished and war torn regions of Africa.